Persepolis Fan Token Debuts on BNB Chain Without Liquidity

Persepolis Fan Token (PRS), a BEP-20 project on BNB Smart Chain, has deployed its token contract and is seeking editorial coverage ahead of a planned presale. At present the token has no public liquidity, no independent security audit, and no completed KYC, meaning it cannot currently be bought, sold, or independently valued.

Onchain Wire verified the contract directly on BNB Smart Chain. The token is named Persepolis, trades under the symbol PRS, uses 18 decimals, and carries a fixed total supply of 6 billion tokens, matching the figures in the project's submission. The contract address is 0x1f67eB3e7487b7D70C69264Ab907Dd074ef1d39f. The project lists its website at prstoken.com and a community channel on Telegram.

No market yet

A check of PancakeSwap, the main decentralized exchange on BNB Smart Chain, returned no liquidity pool for PRS against either BNB or the USDT stablecoin. With no pool in place, the token is not tradable and has no market price. The project states that it remains in a pre-presale phase and that no public liquidity pool has been established.

The team also discloses that independent security auditing and a representative KYC process have not yet been completed. According to its submission, PRS applies 0% contract-level transaction taxes and allocates its supply across eight publicly disclosed wallets, with tokenomics set out in a whitepaper dated August 2026.

What it means for readers

Because PRS has no audit, no KYC, and no liquidity, it carries the elevated risk common to pre-presale tokens: there is no way to exit a position, no third-party review of the contract's security, and no verified team identity. Fan tokens of this kind are speculative, and a deployed contract with a fixed supply is not in itself evidence of a functioning project.

Onchain Wire is reporting the project's current, verifiable status and does not endorse PRS or any token. Nothing here is investment advice. Readers should treat any pre-presale participation as high risk and do their own research.